 Colin Shearn
Concepts (291)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cholestasis | 10 | 2023 | 225 | 3.790 |
Why?
| | Aldehydes | 15 | 2022 | 138 | 3.490 |
Why?
| | PTEN Phosphohydrolase | 7 | 2018 | 140 | 2.750 |
Why?
| | Protein Carbonylation | 10 | 2018 | 51 | 2.720 |
Why?
| | Liver Diseases, Alcoholic | 12 | 2019 | 81 | 2.680 |
Why?
| | Liver | 19 | 2022 | 1633 | 2.560 |
Why?
| | Ethanol | 12 | 2019 | 534 | 2.010 |
Why?
| | Antioxidants | 7 | 2023 | 529 | 1.800 |
Why?
| | Glutathione Transferase | 8 | 2019 | 93 | 1.770 |
Why?
| | Cholangitis, Sclerosing | 3 | 2023 | 66 | 1.500 |
Why?
| | Proto-Oncogene Proteins c-akt | 6 | 2016 | 397 | 1.470 |
Why?
| | Oxidative Stress | 14 | 2019 | 1068 | 1.350 |
Why?
| | Fatty Liver | 3 | 2014 | 209 | 1.130 |
Why?
| | Inflammatory Bowel Diseases | 3 | 2020 | 284 | 1.030 |
Why?
| | Fatty Liver, Alcoholic | 2 | 2016 | 14 | 0.960 |
Why?
| | Carcinoma, Hepatocellular | 3 | 2019 | 210 | 0.920 |
Why?
| | Thioredoxins | 3 | 2018 | 33 | 0.890 |
Why?
| | Mice | 34 | 2023 | 14843 | 0.880 |
Why?
| | AMP-Activated Protein Kinases | 2 | 2014 | 170 | 0.800 |
Why?
| | Abdominal Injuries | 1 | 2023 | 107 | 0.800 |
Why?
| | Protein Processing, Post-Translational | 4 | 2016 | 399 | 0.750 |
Why?
| | Butylated Hydroxytoluene | 2 | 2011 | 31 | 0.680 |
Why?
| | Animals | 36 | 2023 | 31565 | 0.660 |
Why?
| | Hepatocytes | 5 | 2021 | 195 | 0.650 |
Why?
| | Bile Acids and Salts | 5 | 2023 | 171 | 0.650 |
Why?
| | Peroxiredoxins | 2 | 2018 | 23 | 0.640 |
Why?
| | Liver Neoplasms | 4 | 2019 | 504 | 0.640 |
Why?
| | NF-E2-Related Factor 2 | 2 | 2019 | 71 | 0.620 |
Why?
| | Thioredoxin-Disulfide Reductase | 1 | 2018 | 14 | 0.610 |
Why?
| | Parenteral Nutrition | 4 | 2023 | 96 | 0.600 |
Why?
| | Non-alcoholic Fatty Liver Disease | 3 | 2017 | 244 | 0.590 |
Why?
| | Gene Knockout Techniques | 1 | 2018 | 98 | 0.590 |
Why?
| | Liver Diseases | 2 | 2021 | 254 | 0.580 |
Why?
| | Hepatitis | 1 | 2017 | 45 | 0.570 |
Why?
| | Superoxide Dismutase | 5 | 2019 | 305 | 0.550 |
Why?
| | Mitochondrial Proteins | 2 | 2015 | 213 | 0.550 |
Why?
| | End Stage Liver Disease | 1 | 2017 | 61 | 0.540 |
Why?
| | Chemical and Drug Induced Liver Injury, Chronic | 1 | 2016 | 9 | 0.530 |
Why?
| | Thioredoxin Reductase 1 | 3 | 2023 | 8 | 0.520 |
Why?
| | Tandem Mass Spectrometry | 5 | 2022 | 410 | 0.510 |
Why?
| | Liver Cirrhosis, Alcoholic | 1 | 2015 | 17 | 0.510 |
Why?
| | Signal Transduction | 9 | 2021 | 4501 | 0.500 |
Why?
| | Mice, Inbred C57BL | 14 | 2021 | 4680 | 0.490 |
Why?
| | Alcoholism | 3 | 2018 | 710 | 0.480 |
Why?
| | Mice, Knockout | 8 | 2020 | 2562 | 0.460 |
Why?
| | Oxidants | 2 | 2012 | 112 | 0.450 |
Why?
| | Diet, High-Fat | 2 | 2016 | 225 | 0.440 |
Why?
| | Disease Models, Animal | 10 | 2021 | 3498 | 0.430 |
Why?
| | Dietary Fats | 2 | 2018 | 287 | 0.400 |
Why?
| | RNA, Messenger | 6 | 2023 | 2550 | 0.390 |
Why?
| | Male | 27 | 2022 | 55396 | 0.380 |
Why?
| | Lipid Peroxidation | 4 | 2016 | 139 | 0.380 |
Why?
| | Xenobiotics | 1 | 2011 | 24 | 0.370 |
Why?
| | Liver Cirrhosis | 2 | 2023 | 227 | 0.360 |
Why?
| | Chromatography, Liquid | 4 | 2017 | 345 | 0.360 |
Why?
| | Cell Proliferation | 3 | 2018 | 2173 | 0.360 |
Why?
| | Hydrogen Peroxide | 1 | 2012 | 288 | 0.350 |
Why?
| | Alcohol Drinking | 1 | 2016 | 650 | 0.350 |
Why?
| | Oxidoreductases Acting on CH-CH Group Donors | 1 | 2010 | 20 | 0.350 |
Why?
| | Mitochondria | 4 | 2019 | 744 | 0.340 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 2 | 2021 | 192 | 0.340 |
Why?
| | Tumor Necrosis Factor-alpha | 4 | 2023 | 1128 | 0.340 |
Why?
| | Glutathione Reductase | 3 | 2019 | 21 | 0.340 |
Why?
| | Inflammation | 5 | 2023 | 2464 | 0.340 |
Why?
| | Down-Regulation | 1 | 2011 | 594 | 0.310 |
Why?
| | Carcinoma | 1 | 2010 | 198 | 0.310 |
Why?
| | Autophagy | 2 | 2022 | 235 | 0.300 |
Why?
| | Blotting, Western | 4 | 2016 | 1143 | 0.300 |
Why?
| | Alcohol Oxidoreductases | 1 | 2008 | 37 | 0.300 |
Why?
| | Colonic Neoplasms | 1 | 2010 | 212 | 0.300 |
Why?
| | Carcinogens | 1 | 2008 | 102 | 0.290 |
Why?
| | Catalase | 2 | 2017 | 118 | 0.290 |
Why?
| | Phosphoric Monoester Hydrolases | 1 | 2007 | 54 | 0.270 |
Why?
| | NF-kappa B | 2 | 2021 | 636 | 0.270 |
Why?
| | Glutathione | 4 | 2019 | 293 | 0.260 |
Why?
| | Case-Control Studies | 3 | 2018 | 3003 | 0.260 |
Why?
| | Humans | 27 | 2023 | 114045 | 0.260 |
Why?
| | Hep G2 Cells | 3 | 2021 | 59 | 0.250 |
Why?
| | Alanine Transaminase | 3 | 2016 | 141 | 0.250 |
Why?
| | Biomarkers | 1 | 2015 | 3397 | 0.250 |
Why?
| | Up-Regulation | 2 | 2019 | 802 | 0.250 |
Why?
| | Protein Kinase Inhibitors | 1 | 2011 | 784 | 0.250 |
Why?
| | Gene Expression Regulation | 5 | 2021 | 2322 | 0.250 |
Why?
| | Proteomics | 4 | 2019 | 815 | 0.240 |
Why?
| | Recombinant Proteins | 4 | 2020 | 1228 | 0.240 |
Why?
| | Enzyme Inhibitors | 1 | 2008 | 743 | 0.240 |
Why?
| | Macrophage Activation | 2 | 2023 | 163 | 0.240 |
Why?
| | Epithelial Cells | 1 | 2010 | 946 | 0.230 |
Why?
| | Phosphorylation | 3 | 2014 | 1558 | 0.230 |
Why?
| | Lipoproteins | 2 | 2021 | 159 | 0.220 |
Why?
| | ARNTL Transcription Factors | 1 | 2023 | 13 | 0.220 |
Why?
| | Genes, Regulator | 1 | 2023 | 34 | 0.220 |
Why?
| | Cysteine Proteinase Inhibitors | 2 | 2014 | 45 | 0.210 |
Why?
| | Prostatic Neoplasms | 1 | 2010 | 913 | 0.210 |
Why?
| | Insulin Resistance | 1 | 2011 | 1072 | 0.210 |
Why?
| | Sulfhydryl Compounds | 2 | 2018 | 176 | 0.210 |
Why?
| | Triglycerides | 2 | 2016 | 467 | 0.200 |
Why?
| | Fatty Acid-Binding Proteins | 2 | 2013 | 60 | 0.200 |
Why?
| | Enzyme Activation | 3 | 2013 | 771 | 0.200 |
Why?
| | Mitochondria, Liver | 2 | 2013 | 67 | 0.200 |
Why?
| | Dioxanes | 1 | 2021 | 5 | 0.190 |
Why?
| | Oxidation-Reduction | 3 | 2019 | 917 | 0.190 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2023 | 144 | 0.190 |
Why?
| | Isoxazoles | 1 | 2021 | 51 | 0.190 |
Why?
| | Phytosterols | 1 | 2021 | 11 | 0.190 |
Why?
| | Models, Molecular | 4 | 2014 | 1368 | 0.180 |
Why?
| | Cholesterol | 2 | 2020 | 368 | 0.180 |
Why?
| | Phosphatidylinositol 4,5-Diphosphate | 1 | 2020 | 24 | 0.180 |
Why?
| | Mucoproteins | 1 | 2020 | 10 | 0.180 |
Why?
| | Phosphatidylcholines | 1 | 2020 | 132 | 0.170 |
Why?
| | Vesicular Transport Proteins | 1 | 2020 | 82 | 0.170 |
Why?
| | Gene Expression | 2 | 2021 | 1417 | 0.170 |
Why?
| | Liposomes | 1 | 2020 | 146 | 0.170 |
Why?
| | Cell Adhesion Molecules | 1 | 2020 | 167 | 0.170 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 2013 | 465 | 0.160 |
Why?
| | Female | 9 | 2021 | 59324 | 0.160 |
Why?
| | Acylation | 1 | 2019 | 28 | 0.160 |
Why?
| | Lysosomes | 1 | 2019 | 123 | 0.160 |
Why?
| | Lung | 1 | 2011 | 3521 | 0.160 |
Why?
| | Colon | 1 | 2020 | 232 | 0.160 |
Why?
| | PPAR alpha | 2 | 2016 | 52 | 0.150 |
Why?
| | Ribosomes | 1 | 2019 | 148 | 0.150 |
Why?
| | Mice, 129 Strain | 1 | 2018 | 77 | 0.150 |
Why?
| | Reactive Oxygen Species | 2 | 2011 | 522 | 0.150 |
Why?
| | Heme Oxygenase-1 | 1 | 2018 | 51 | 0.150 |
Why?
| | Sulfinic Acids | 1 | 2018 | 7 | 0.150 |
Why?
| | Colitis | 1 | 2020 | 223 | 0.150 |
Why?
| | Pyruvaldehyde | 1 | 2018 | 27 | 0.150 |
Why?
| | Aminobutyrates | 1 | 2018 | 31 | 0.150 |
Why?
| | Middle Aged | 4 | 2019 | 26605 | 0.150 |
Why?
| | Azo Compounds | 1 | 2017 | 25 | 0.140 |
Why?
| | Taurine | 1 | 2018 | 41 | 0.140 |
Why?
| | Organ Specificity | 1 | 2018 | 266 | 0.140 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2017 | 61 | 0.140 |
Why?
| | Malnutrition | 1 | 2018 | 62 | 0.140 |
Why?
| | Protein Structure, Secondary | 1 | 2018 | 325 | 0.140 |
Why?
| | Cell Line, Tumor | 3 | 2020 | 2700 | 0.140 |
Why?
| | Gene Deletion | 2 | 2015 | 356 | 0.140 |
Why?
| | Homocystinuria | 1 | 2018 | 62 | 0.140 |
Why?
| | Mice, Inbred BALB C | 2 | 2011 | 1144 | 0.140 |
Why?
| | Adult | 4 | 2019 | 30375 | 0.130 |
Why?
| | Amino Acid Sequence | 4 | 2015 | 1981 | 0.130 |
Why?
| | Lipogenesis | 1 | 2016 | 56 | 0.130 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2016 | 84 | 0.130 |
Why?
| | Sirtuin 3 | 2 | 2019 | 51 | 0.130 |
Why?
| | Lysine | 1 | 2017 | 241 | 0.130 |
Why?
| | Proteome | 1 | 2019 | 337 | 0.120 |
Why?
| | Acetylation | 4 | 2017 | 209 | 0.120 |
Why?
| | Cytochrome P-450 CYP4A | 1 | 2014 | 4 | 0.120 |
Why?
| | Protein Isoforms | 1 | 2015 | 337 | 0.120 |
Why?
| | Protein Binding | 4 | 2020 | 1888 | 0.110 |
Why?
| | CD36 Antigens | 1 | 2014 | 36 | 0.110 |
Why?
| | Computational Biology | 1 | 2017 | 528 | 0.110 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2014 | 92 | 0.110 |
Why?
| | Heat-Shock Proteins | 1 | 2014 | 112 | 0.110 |
Why?
| | Phosphatidylinositol 3-Kinases | 2 | 2013 | 328 | 0.110 |
Why?
| | Carrier Proteins | 1 | 2017 | 694 | 0.110 |
Why?
| | Central Nervous System Depressants | 1 | 2014 | 80 | 0.110 |
Why?
| | Adenosine Triphosphatases | 1 | 2014 | 152 | 0.110 |
Why?
| | DNA Primers | 2 | 2012 | 508 | 0.110 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2013 | 33 | 0.110 |
Why?
| | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2013 | 24 | 0.110 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 1 | 2013 | 54 | 0.100 |
Why?
| | Molecular Sequence Data | 3 | 2015 | 2783 | 0.100 |
Why?
| | Endoplasmic Reticulum | 2 | 2014 | 234 | 0.100 |
Why?
| | Polymerase Chain Reaction | 2 | 2016 | 990 | 0.100 |
Why?
| | Models, Chemical | 1 | 2014 | 248 | 0.100 |
Why?
| | Organ Size | 1 | 2013 | 434 | 0.100 |
Why?
| | Adiponectin | 1 | 2013 | 213 | 0.090 |
Why?
| | Reactive Nitrogen Species | 1 | 2011 | 21 | 0.090 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2011 | 60 | 0.090 |
Why?
| | Peptide Mapping | 1 | 2011 | 60 | 0.090 |
Why?
| | Binding Sites | 2 | 2020 | 1166 | 0.090 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2011 | 77 | 0.090 |
Why?
| | Receptors, Estrogen | 1 | 2013 | 371 | 0.090 |
Why?
| | Oxygen Consumption | 1 | 2013 | 587 | 0.090 |
Why?
| | Crotonates | 1 | 2010 | 3 | 0.090 |
Why?
| | Toluidines | 1 | 2010 | 6 | 0.090 |
Why?
| | Hydroxybutyrates | 1 | 2010 | 11 | 0.090 |
Why?
| | Tumor Cells, Cultured | 1 | 2012 | 845 | 0.090 |
Why?
| | Fenretinide | 1 | 2010 | 7 | 0.090 |
Why?
| | Cell Line, Transformed | 1 | 2010 | 133 | 0.080 |
Why?
| | Microscopy, Confocal | 1 | 2011 | 304 | 0.080 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2011 | 167 | 0.080 |
Why?
| | Nitriles | 1 | 2010 | 149 | 0.080 |
Why?
| | Protein Conformation | 1 | 2012 | 803 | 0.080 |
Why?
| | Glycoproteins | 1 | 2011 | 304 | 0.080 |
Why?
| | Cell Survival | 1 | 2012 | 1014 | 0.080 |
Why?
| | Alkylation | 1 | 2008 | 18 | 0.080 |
Why?
| | Nuclear Proteins | 1 | 2013 | 591 | 0.080 |
Why?
| | Kidney | 1 | 2015 | 1182 | 0.080 |
Why?
| | DNA Damage | 2 | 2021 | 351 | 0.070 |
Why?
| | RNA, Small Interfering | 1 | 2010 | 534 | 0.070 |
Why?
| | Cytosol | 1 | 2008 | 201 | 0.070 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2008 | 161 | 0.070 |
Why?
| | Lung Neoplasms | 2 | 2011 | 2159 | 0.070 |
Why?
| | Base Sequence | 1 | 2011 | 2114 | 0.070 |
Why?
| | Cells, Cultured | 2 | 2013 | 3861 | 0.070 |
Why?
| | Phosphatidylinositol Phosphates | 1 | 2007 | 38 | 0.070 |
Why?
| | Immunohistochemistry | 1 | 2011 | 1624 | 0.070 |
Why?
| | Static Electricity | 1 | 2007 | 112 | 0.070 |
Why?
| | Hydrolysis | 1 | 2007 | 173 | 0.070 |
Why?
| | Amino Acid Substitution | 1 | 2007 | 261 | 0.070 |
Why?
| | Rats, Sprague-Dawley | 1 | 2011 | 2182 | 0.060 |
Why?
| | Cloning, Molecular | 2 | 2020 | 522 | 0.060 |
Why?
| | Peptides | 1 | 2011 | 847 | 0.060 |
Why?
| | Skin | 1 | 2010 | 653 | 0.060 |
Why?
| | Metabolome | 2 | 2019 | 274 | 0.060 |
Why?
| | Phospholipids | 1 | 2007 | 194 | 0.060 |
Why?
| | Transcription Factors | 1 | 2013 | 1526 | 0.060 |
Why?
| | Biomarkers, Tumor | 1 | 2011 | 1032 | 0.060 |
Why?
| | Glycosylation | 2 | 2016 | 130 | 0.050 |
Why?
| | Amino Acids | 2 | 2018 | 445 | 0.050 |
Why?
| | Rats | 1 | 2011 | 4913 | 0.050 |
Why?
| | Sterols | 1 | 2021 | 17 | 0.050 |
Why?
| | Multidrug Resistance-Associated Proteins | 1 | 2021 | 34 | 0.050 |
Why?
| | Fatty Acids | 2 | 2016 | 380 | 0.050 |
Why?
| | Systems Analysis | 1 | 2021 | 21 | 0.050 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 2 | 2012 | 99 | 0.050 |
Why?
| | Intestinal Diseases | 1 | 2021 | 33 | 0.050 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2021 | 73 | 0.050 |
Why?
| | Bilirubin | 1 | 2021 | 88 | 0.050 |
Why?
| | Infliximab | 1 | 2021 | 93 | 0.050 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2021 | 121 | 0.050 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2021 | 128 | 0.050 |
Why?
| | Apoptosis | 1 | 2010 | 2349 | 0.050 |
Why?
| | Calcium | 1 | 2007 | 1089 | 0.050 |
Why?
| | Sphingomyelins | 1 | 2020 | 26 | 0.050 |
Why?
| | Protein Conformation, beta-Strand | 1 | 2020 | 15 | 0.050 |
Why?
| | Ursodeoxycholic Acid | 1 | 2020 | 20 | 0.040 |
Why?
| | Phosphatidylinositols | 1 | 2020 | 53 | 0.040 |
Why?
| | Phosphatidylethanolamines | 1 | 2020 | 66 | 0.040 |
Why?
| | Dextran Sulfate | 1 | 2020 | 70 | 0.040 |
Why?
| | Molecular Docking Simulation | 1 | 2020 | 101 | 0.040 |
Why?
| | Phosphatidylserines | 1 | 2020 | 87 | 0.040 |
Why?
| | Gene Knockdown Techniques | 1 | 2021 | 301 | 0.040 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2020 | 129 | 0.040 |
Why?
| | Lipid Bilayers | 1 | 2020 | 94 | 0.040 |
Why?
| | Aged | 1 | 2017 | 18969 | 0.040 |
Why?
| | Genetic Vectors | 1 | 2020 | 287 | 0.040 |
Why?
| | Interleukin-1beta | 1 | 2021 | 368 | 0.040 |
Why?
| | Crystallography, X-Ray | 1 | 2020 | 402 | 0.040 |
Why?
| | Molecular Dynamics Simulation | 1 | 2020 | 200 | 0.040 |
Why?
| | Sirtuins | 1 | 2019 | 32 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2020 | 316 | 0.040 |
Why?
| | gamma-Glutamyltransferase | 1 | 2018 | 42 | 0.040 |
Why?
| | Metabolic Networks and Pathways | 1 | 2019 | 167 | 0.040 |
Why?
| | Cystathionine beta-Synthase | 1 | 2018 | 59 | 0.040 |
Why?
| | Escherichia coli | 1 | 2020 | 723 | 0.030 |
Why?
| | Insulin-Secreting Cells | 1 | 2020 | 317 | 0.030 |
Why?
| | F2-Isoprostanes | 1 | 2016 | 14 | 0.030 |
Why?
| | Protein D-Aspartate-L-Isoaspartate Methyltransferase | 1 | 2016 | 5 | 0.030 |
Why?
| | Mutation | 1 | 2007 | 3338 | 0.030 |
Why?
| | Sumoylation | 1 | 2016 | 15 | 0.030 |
Why?
| | Oxides | 1 | 2016 | 40 | 0.030 |
Why?
| | Methylation | 1 | 2016 | 208 | 0.030 |
Why?
| | Chemokine CXCL2 | 1 | 2014 | 41 | 0.030 |
Why?
| | Macrophages | 1 | 2021 | 1259 | 0.030 |
Why?
| | Receptor, Platelet-Derived Growth Factor beta | 1 | 2014 | 25 | 0.030 |
Why?
| | Oxidative Phosphorylation | 1 | 2015 | 154 | 0.030 |
Why?
| | Lipopolysaccharide Receptors | 1 | 2014 | 81 | 0.030 |
Why?
| | Unfolded Protein Response | 1 | 2014 | 44 | 0.030 |
Why?
| | Matrix Metalloproteinases | 1 | 2014 | 89 | 0.030 |
Why?
| | Protein Folding | 1 | 2014 | 239 | 0.030 |
Why?
| | Antibodies | 1 | 2014 | 365 | 0.030 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2013 | 126 | 0.030 |
Why?
| | Actins | 1 | 2014 | 376 | 0.030 |
Why?
| | Anilino Naphthalenesulfonates | 1 | 2012 | 10 | 0.030 |
Why?
| | Fibrosis | 1 | 2014 | 452 | 0.030 |
Why?
| | Lipid Metabolism | 1 | 2015 | 441 | 0.030 |
Why?
| | Disease Progression | 1 | 2019 | 2371 | 0.020 |
Why?
| | Transforming Growth Factor beta | 1 | 2014 | 445 | 0.020 |
Why?
| | Ubiquitination | 1 | 2012 | 86 | 0.020 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2013 | 270 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2012 | 151 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2014 | 796 | 0.020 |
Why?
| | Transcriptome | 1 | 2016 | 723 | 0.020 |
Why?
| | Microsomes, Liver | 1 | 2011 | 54 | 0.020 |
Why?
| | NAD | 1 | 2011 | 63 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2011 | 323 | 0.020 |
Why?
| | Hypoxia | 1 | 2016 | 956 | 0.020 |
Why?
| | Computer Simulation | 1 | 2014 | 873 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 924 | 0.020 |
Why?
| | Lipids | 1 | 2013 | 564 | 0.020 |
Why?
| | Mass Spectrometry | 1 | 2012 | 622 | 0.020 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2013 | 1145 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2013 | 1947 | 0.020 |
Why?
| | Cytokines | 1 | 2014 | 1824 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2013 | 2090 | 0.010 |
Why?
| | Adolescent | 1 | 2016 | 17800 | 0.010 |
Why?
| | Child | 1 | 2016 | 18401 | 0.010 |
Why?
|
|
Shearn's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|